BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3337898)

  • 1. Platelet-agglutinating protein P37 from a thrombotic thrombocytopenic purpura plasma forms a complex with human immunoglobulin G.
    Siddiqui FA; Lian EC
    Blood; 1988 Feb; 71(2):299-304. PubMed ID: 3337898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of platelet agglutinating protein p37 from the plasma of a patient with thrombotic thrombocytopenic purpura to human platelets.
    Lian EC; Siddiqui FA
    Thromb Haemost; 1991 Jan; 65(1):96-101. PubMed ID: 2024244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electron microscopic study of platelet agglutination induced by thrombotic thrombocytopenic purpura plasma containing 37-KDa platelet agglutinating protein.
    Li JZ; Liu JW; Benito G; Siddiqui FA; Lian EC
    Thromb Res; 1989 Sep; 55(6):757-66. PubMed ID: 2781535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-agglutinating protein p37 from a thrombotic thrombocytopenic purpura plasma forms complexes with platelet membrane glycoprotein IV (CD36).
    Siddiqui FA; Lian EC
    Biochem Int; 1992 Jul; 27(3):485-96. PubMed ID: 1384492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet agglutinating protein p37 causes platelet agglutination through its binding to membrane glycoprotein IV.
    Lian EC; Siddiqui FA; Jamieson GA; Tandon NN
    Thromb Haemost; 1991 Jan; 65(1):102-6. PubMed ID: 2024231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma.
    Siddiqui FA; Lian EC
    J Clin Invest; 1985 Oct; 76(4):1330-7. PubMed ID: 3932464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-agglutinating protein p37 from a patient with thrombotic thrombocytopenic purpura has characteristics similar to prethrombin 2.
    Kim SH; Park SJ; Lee JW; Jin JY
    J Biochem Mol Biol; 2002 Sep; 35(5):524-31. PubMed ID: 12359097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of platelet agglutinating protein p37 purified from the plasma of a patient with thrombotic thrombocytopenic purpura.
    Siddiqui FA; Lian EC
    Biochem Mol Biol Int; 1993 Jun; 30(2):385-95. PubMed ID: 8364416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Purification and some properties of platelet aggregating protein (PAP) from the plasma of a patient with thrombotic thrombocytopenic purpura].
    Chen SH
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):382-4, 28. PubMed ID: 2598093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G.
    Lian EC; Mui PT; Siddiqui FA; Chiu AY; Chiu LL
    J Clin Invest; 1984 Feb; 73(2):548-55. PubMed ID: 6538207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies investigating platelet aggregation and release initiated by sera from patients with thrombotic thrombocytopenic purpura.
    Kelton JG; Moore JC; Murphy WG
    Blood; 1987 Mar; 69(3):924-8. PubMed ID: 3493046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells.
    Burns ER; Zucker-Franklin D
    Blood; 1982 Oct; 60(4):1030-7. PubMed ID: 7052160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
    Moore JC; Murphy WG; Kelton JG
    Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic thrombocytopenic purpura plasma enhances platelet-leucocyte interaction in vitro.
    Valant PA; Jy W; Horstman LL; Mao WW; Ahn YS
    Br J Haematol; 1998 Jan; 100(1):24-32. PubMed ID: 9450786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Moake JL; McPherson PD
    Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.
    Tsai HM; Rice L; Sarode R; Chow TW; Moake JL
    Ann Intern Med; 2000 May; 132(10):794-9. PubMed ID: 10819702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of a platelet-agglutinating factor in thrombotic thrombocytopenic purpura.
    Kelton JG; Moore J; Santos A; Sheridan D
    Ann Intern Med; 1984 Nov; 101(5):589-93. PubMed ID: 6333196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and some properties of a protein obtained from normal human plasma which inhibits the platelet aggregation induced by thrombotic thrombocytopenic purpura plasma.
    Lian EC; Mui PT; Siddiqui FA; Chiu LL
    Thromb Res; 1984 Jan; 33(1):69-76. PubMed ID: 6420930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma.
    Lian EC; Harkness DR; Byrnes JJ; Wallach H; Nunez R
    Blood; 1979 Feb; 53(2):333-8. PubMed ID: 570069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic thrombocytopenic purpura.
    Lian EC
    Annu Rev Med; 1988; 39():203-12. PubMed ID: 3285772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.